Genetic test could spare breast cancer patients from chemotherapy

More women with breast cancer could be spared chemotherapy if doctors switched to a new genetic test, research shows.

The EndoPredict test can more accurately predict whether a woman’s cancer will spread around the body than the standard test used on the NHS.

It also can produce results in just a few days compared to around 14 days for the current test, Oncotype DX, which has to be posted to the the US.